Munich, Germany & Singapore, August 28, 2025 — For the cardiologist facing a full waiting room, every minute counts. Yet echocardiography, the backbone of cardiac diagnosis, often requires time-consuming manual measurements and depends on specialized expertise. As a result, conditions such as cardiac amyloidosis frequently remain undetected until late stages when treatment options are limited.
deepc is partnering with Us2.ai to change this. Through this collaboration, Us2.ai’s FDA-cleared and CE-marked software becomes available within the deepcOS® platform, providing healthcare providers with real-time, automated echocardiography analysis and reporting seamlessly integrated in their clinical workflows.
Clinical Evidence Driving Confidence
Us2.ai automates over 150 measurements, from chamber dimensions to systolic and diastolic function, global and regional strain, and aortic stenosis metrics. In a recent multi-center study involving more than 500 patients, the solution achieved over 90% accuracy in detecting cardiac amyloidosis while reducing analysis time to minutes. Additional studies confirm its ability to track disease progression over time, correlating echo-derived metrics with patient outcomes and survival data.
Empowering Clinicians Through Integrated AI
By integrating these capabilities through deepcOS®, hospitals can deploy advanced echocardiography AI without disrupting existing systems or workflows.
Together, deepc and Us2.ai aim to accelerate diagnosis, improve consistency, and expand access to expert-level cardiac imaging for healthcare teams worldwide. How this integration supports earlier answers for their patients can be seen by visiting the deepcOS® storefront.
About deepc
deepc has developed the radiology AI platform deepcOS®, providing clinicians with effortless access to a myriad of globally approved, regulatory-leading AI solutions for more than 80 clinical indications, delivering more efficient workflows, and offering radiologists assistance in their daily routine. With its rigorous validation of vendor-neutral AI solutions using large-scale independent data, as well as offering a practical evaluation of AI solutions on local clinical data, deepc ensures that radiologists benefit from the best AI solutions that meet their unique requirements. deepc enables easy and fast installation and end-to-end integration to make access to AI effortless in any clinical setting.
About Us2.ai
Us2.ai is a pioneer in the development of AI technology for cardiovascular care. The company’s mission is to leverage advanced AI algorithms to assist healthcare professionals in diagnosing and treating heart disease more accurately and efficiently. Us2.ai ’s solution is cleared in over 30 countries, including the FDA and CE Mark, and is designed to integrate seamlessly into clinical workflows, providing valuable insights that improve patient care and outcomes.
Learn more at us2.ai.
.png)